echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > CSPC will win $9 billion star anticoagulant

    CSPC will win $9 billion star anticoagulant

    • Last Update: 2021-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, CSPC has entered the administrative examination and approval stage with the imitation of the 4 types of apixaban tablets, and is expected to be approved for listing in the near future


    Apixaban is a highly selective direct factor Xa inhibitor jointly developed by Bristol-Myers Squibb and Pfizer.


    Bristol-Myers Squibb Eliquis global sales (unit: million dollars)

    Source: Mynet.


    Apixaban was first approved for listing in China in 2013, and the previous market sales have been bleak, and the market scale has grown by leaps and bounds in recent years


    Apixaban tablets have been included in the third batch of centralized procurement.


    As a popular product, there are more than 30 companies with Apixaban tablets.


    Data source: Mi Neiwang database

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.